Science
Synlogic Publishes Papers in Nature Journals Demonstrating Proof-of-Mechanism and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU) – StreetInsider.com
CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative…
CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today the publication of two papers in the journals Nature Metabolism…
Continue Reading
-
General22 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General18 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business18 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General18 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts